共 50 条
- [43] SUBCUTANEOUS GROWTH HORMONE-RELEASING HORMONE-THERAPY IN GROWTH HORMONE-DEFICIENT CHILDREN - 1ST YEAR OF THERAPY [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (04): : 1115 - 1120
- [44] SIMILARITY OF RESPONSE OF GROWTH-HORMONE DEFICIENT CHILDREN TO LOW AND HIGH DOSE GROWTH-HORMONE THERAPY [J]. CLINICAL RESEARCH, 1978, 26 (06): : A843 - A843
- [45] Rapid decrease of urinary pyridinoline excretion in growth hormone deficient children following discontinuation of growth hormone therapy [J]. ACTA PAEDIATRICA JAPONICA, 1997, 39 (01): : 18 - 20
- [46] SHORT-TERM RESULTS OF RECOMBINANT GROWTH-HORMONE THERAPY IN GROWTH-HORMONE DEFICIENT CHILDREN [J]. ACTA PAEDIATRICA SCANDINAVICA, 1988, : 220 - 221
- [47] Molecular genetics of growth hormone deficient children: correlation with auxology and response to first year of growth hormone therapy [J]. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2017, 30 (06): : 669 - 675
- [48] Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (03): : 1189 - 1196
- [50] Use of growth hormone for non-growth hormone deficient children [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (23): : 1878 - 1878